Hyperuricemia Remission After Sleeve Gastrectomy in Chinese Patients and Establishment of a Preoperative Predictive Model: A Retrospective Cohort Study with a Mean Follow-Up of 20 Months.

IF 3 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Xiyuan Chen, Zhehong Li, Zheng Wang, Yilan Sun, Mingyue Shang, Chenxu Tian, Zhaohui Liao, Dongbo Lian, Buhe Amin, Dexiao Du, Guangzhong Xu, Nengwei Zhang, Liang Wang
{"title":"Hyperuricemia Remission After Sleeve Gastrectomy in Chinese Patients and Establishment of a Preoperative Predictive Model: A Retrospective Cohort Study with a Mean Follow-Up of 20 Months.","authors":"Xiyuan Chen, Zhehong Li, Zheng Wang, Yilan Sun, Mingyue Shang, Chenxu Tian, Zhaohui Liao, Dongbo Lian, Buhe Amin, Dexiao Du, Guangzhong Xu, Nengwei Zhang, Liang Wang","doi":"10.2147/DMSO.S508015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A significant proportion of patients with obesity have comorbid hyperuricemia (HUA). However, the curative effect of sleeve gastrectomy (SG) on HUA remains debated.</p><p><strong>Objective: </strong>To clarify the remission effect of SG on HUA, analyze potential influencing factors, and establish a predictive model using preoperative data.</p><p><strong>Methods: </strong>Pre- and post-operative data from 130 patients with obesity and HUA who underwent SG in our hospital were collected and evaluated for the therapeutic effect on HUA. Binary logistic regression analysis was employed to screen the influencing factors and the ones with predictive value. Predictive model was constructed, then evaluated using the area under the receiver operating characteristic (ROC) curve (AUC) and internal and external validations. Complete remission of HUA was defined as a follow-up SUA level that no longer met the reference value for diagnosing HUA, i.e., an SUA concentration of <428 μmol/L (in males) or <357 μmol/L (in females), according to the reference value in our hospital's laboratory.</p><p><strong>Results: </strong>The mean follow-up duration is 20.4 months. After ≥ one year post SG, the complete remission rate of HUA was 58%. Preoperative hip circumference (HC) and preoperative serum uric acid (SUA) level were found to be predictive variables, the AUC values of which, along with their combination in predicting this outcome, were 0.696, 0.731, 0.738, respectively, p >0.05. The joint predictive model was found to have a sensitivity and specificity of 0.776 and 0.738, respectively, and its reliability was confirmed by internal and external validations.</p><p><strong>Conclusion: </strong>Some patients can achieve HUA complete remission following SG after 1 year. Preoperative SUA concentration and HC can be utilized to predict this outcome in Chinese patients with obesity. The joint predictive model offers potentially better clinical value.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"2825-2836"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357586/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S508015","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A significant proportion of patients with obesity have comorbid hyperuricemia (HUA). However, the curative effect of sleeve gastrectomy (SG) on HUA remains debated.

Objective: To clarify the remission effect of SG on HUA, analyze potential influencing factors, and establish a predictive model using preoperative data.

Methods: Pre- and post-operative data from 130 patients with obesity and HUA who underwent SG in our hospital were collected and evaluated for the therapeutic effect on HUA. Binary logistic regression analysis was employed to screen the influencing factors and the ones with predictive value. Predictive model was constructed, then evaluated using the area under the receiver operating characteristic (ROC) curve (AUC) and internal and external validations. Complete remission of HUA was defined as a follow-up SUA level that no longer met the reference value for diagnosing HUA, i.e., an SUA concentration of <428 μmol/L (in males) or <357 μmol/L (in females), according to the reference value in our hospital's laboratory.

Results: The mean follow-up duration is 20.4 months. After ≥ one year post SG, the complete remission rate of HUA was 58%. Preoperative hip circumference (HC) and preoperative serum uric acid (SUA) level were found to be predictive variables, the AUC values of which, along with their combination in predicting this outcome, were 0.696, 0.731, 0.738, respectively, p >0.05. The joint predictive model was found to have a sensitivity and specificity of 0.776 and 0.738, respectively, and its reliability was confirmed by internal and external validations.

Conclusion: Some patients can achieve HUA complete remission following SG after 1 year. Preoperative SUA concentration and HC can be utilized to predict this outcome in Chinese patients with obesity. The joint predictive model offers potentially better clinical value.

中国患者袖式胃切除术后高尿酸血症缓解及术前预测模型的建立:一项平均随访20个月的回顾性队列研究
背景:相当比例的肥胖患者合并高尿酸血症(HUA)。然而,袖式胃切除术(SG)对HUA的疗效仍有争议。目的:明确SG对HUA的缓解作用,分析可能的影响因素,并利用术前数据建立预测模型。方法:收集我院接受SG治疗的130例肥胖合并HUA患者的术前、术后资料,评价其治疗HUA的效果。采用二元logistic回归分析筛选影响因素和具有预测价值的因素。建立预测模型,采用受试者工作特征曲线下面积(AUC)和内外验证对预测结果进行评价。HUA完全缓解定义为随访SUA水平不再满足诊断HUA的参考值,即SUA浓度:结果:平均随访时间为20.4个月。SG后≥1年,HUA完全缓解率为58%。术前臀围(HC)和术前血清尿酸(SUA)水平为预测变量,其AUC值及其联合预测结果分别为0.696、0.731、0.738,p < 0.05。联合预测模型的灵敏度和特异度分别为0.776和0.738,并通过内外验证验证了其可靠性。结论:部分患者SG术后1年HUA完全缓解。术前SUA浓度和HC可用于预测中国肥胖患者的这一结果。联合预测模型具有更好的临床应用价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信